• Fate Therapeutics (NASDAQ:FATE) Rating Lowered to "Sell" at StockNews.com

    Source: Buzz FX / 11 Mar 2025 02:31:17   America/New_York


    Fate Therapeutics (NASDAQ:FATE) Rating Lowered to "Sell" at StockNews.com Written by MarketBeat March 11, 2025 Share Link copied to clipboard. Remove Ads Fate Therapeutics ( NASDAQ:FATE - Get Free Report ) was downgraded by equities researc
    Read more...
Share on,